Global Albumin Excipient Market
Pharmaceuticals

Future Projections: Albumin Excipient Market to Reach $6.64 Million by 2029 at 6.6% CAGR

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

How Much Is the Global Albumin Excipient Market Valued at Present and by 2029?

The market size for albumin excipient has seen a robust growth in the past few years. It is projected to increase from $4.85 billion in 2024 to $5.15 billion in 2025, with a compound annual growth rate (CAGR) of 6.1%. Factors like the expansion of the biopharmaceutical industry, broader acceptance of biologics, higher occurrence of chronic conditions, progress in clinical procedures and drug development, as well as a heightened emphasis on drug delivery have contributed to the growth in the historical period.

In the coming years, the albumin excipient market size is anticipated to witness robust growth. It is projected to increase to “$6.64 billion in 2029, with a compound annual growth rate (CAGR) of 6.6%. ” The growth predicted during this period can be linked to the ongoing expansion of biopharmaceuticals, a growing pipeline of biologics, an increasing elderly population, worldwide vaccination efforts, and larger investments in drug development. Significant trends during this period are expected to be biodegradable and biocompatible attributes, collaborations, and partnerships in research, regulatory adherence, quality standards, applications in cell therapy, as well as customization and personalized solutions.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=10672&type=smp

#What Drivers Are Influencing Growth In The Albumin Excipient Market?

The escalation of persistent illnesses is anticipated to drive the expansion of the albumin excipient market in the future. Persistent illnesses are those that endure for more than three months and have the potential to worsen over time. Albumin, a versatile protein carrier used for drug targeting and enhancing the pharmacokinetic profile of peptide or protein-based drugs, is often applied as a blood volumizer, and it is the most common circulating protein found in plasma. This protein is utilized in treating various conditions, including but not limited to cancer and diabetes. For example, the World Health Organization, a Switzerland-based United Nations agency, projected in February 2024 that more than 35 million new cancer cases will develop by 2050. This marks a 77% rise compared to the anticipated 20 million cancer cases in 2022. Hence, the escalating prevalence of persistent diseases is fueling the albumin excipient market’s growth.

What Are The Main Segments Identified In The Albumin Excipient Market Research?

The albumin excipient market covered in this report is segmented –

1) By Product: Human Serum Albumin, Recombinant Albumin

2) By End-Users: Pharmaceutical And Biotechnology Industry, Research Institutes, Other End Users

Subsegments:

1) By Human Serum Albumin: 5% Human Serum Albumin, 20% Human Serum Albumin

2) By Recombinant Albumin: Recombinant Human Serum Albumin, Recombinant Bovine Serum Albumin

How Are Key Trends Driving Expansion In The Albumin Excipient Industry?

Leading firms in the albumin excipient market are utilizing strategic alliances to cater to necessary biotechnology and pharmaceutical industries. Strategic alliances constitute a method wherein businesses take advantage of each other’s capabilities and assets to attain shared advantages and success. For example, in October 2023, ARTES Biotechnology GmbH, a biotech company based in Germany, aligned with Basic Pharma, a pharmaceutical company originating from Netherlands, to escalate the production of recombinant protein. Through this alliance, they plan to advance the production of pharmaceutical recombinant protein by enhancing the supply chain and reducing the timeline for launching new products.

Which Companies Play A Key Role In The Development Of The Albumin Excipient Market?

Major companies operating in the albumin excipient market include Albumin Therapeutics LLC, Biotest AG, CSL Behring,Grifols S.A., HiMedia Laboratories LLC, InVitria Inc., Medxbio Pte Ltd., Octapharma AG, RayBiotech Inc., SeraCare Life Sciences Inc., Sigma-Aldrich Pty. Ltd., Hualan Biological Engineering Inc., Kedrion Biopharma, LFB USA Inc., Shanghai RAAS Blood Products Co. Ltd., Baxter International Inc., Merck KGaA, Thermo Fisher Scientific Inc., Albumedix A/S, Bio Products Laboratory Ltd., Shire Plc., Ventria Bioscience Inc., Novartis AG, China Biologic Products Holdings Inc., ProMetic Life Sciences Inc., Sanquin, Biopharma, Takeda Pharmaceutical Company Limited, FUJIFILM Irvine Scientific Inc.

Get The Full Report Here:

https://www.thebusinessresearchcompany.com/report/albumin-excipient-global-market-report

What Are The Key Regional Developments Shaping The Albumin Excipient Market?

North America was the largest region in the Albumin Excipient market in 2024.Asia-Pacific is expected to be the fastest-growing region in the global albumin excipient market report during the forecast period. The regions covered in the albumin excipient market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=10672&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model